Rxivist logo

Cancer Genome Interpreter Annotates The Biological And Clinical Relevance Of Tumor Alterations

By David Tamborero, Carlota Rubio-Perez, Jordi Deu-Pons, Michael P. Schroeder, Ana Vivancos, Ana Rovira, Ignasi Tusquets, Joan Albanell, Jordi Rodon, Josep Tabernero, Carmen de Torres, Rodrigo Dienstmann, Abel Gonzalez-Perez, Nuria Lopez-Bigas

Posted 20 May 2017
bioRxiv DOI: 10.1101/140475 (published DOI: 10.1186/s13073-018-0531-8)

While tumor genome sequencing has become widely available in clinical and research settings, the interpretation of tumor somatic variants remains an important bottleneck. Most of the alterations observed in tumors, including those in well-known cancer genes, are of uncertain significance. Moreover, the information on tumor genomic alterations shaping the response to existing therapies is fragmented across the literature and several specialized resources. Here we present the Cancer Genome Interpreter (http://www.cancergenomeinterpreter.org), an open access tool that we have implemented to annotate genomic alterations and interpret their possible role in tumorigenesis and in the response to anti-cancer therapies.

Download data

  • Downloaded 2,560 times
  • Download rankings, all-time:
    • Site-wide: 8,951
    • In cancer biology: 146
  • Year to date:
    • Site-wide: 52,772
  • Since beginning of last month:
    • Site-wide: 41,169

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide